Literature DB >> 11384963

BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells.

O Aprelikova1, A J Pace, B Fang, B H Koller, E T Liu.   

Abstract

BRCA1 gene is a tumor suppressor for breast and ovarian cancers with the putative role in DNA repair and transcription. To characterize the role of BRCA1 in transcriptional regulation, we analyzed gene expression profiles of mouse embryonic stem cells deficient in BRCA1 using microarray technology. We found that loss of BRCA1 correlated with decreased expression of several groups of genes including stress response genes, cytoskeleton genes, and genes involved in protein synthesis and degradation. Previous study showed that BRCA1 is a transcriptional co-activator of p53 protein; however the majority of p53 target genes remained at the same expression levels in BRCA1 knockout cells as in the wild type cells. The only p53 target gene down-regulated with the loss of BRCA1 was 14-3-3 sigma, a major G(2)/M checkpoint control gene. Similar to cells with decreased 14-3-3 sigma activity, BRCA1-deficient cells were unable to sustain G(2)/M growth arrest after exposure to ionizing radiation. We find that BRCA1 induction of 14-3-3 sigma requires the presence of wild type p53 and can be regulated by a minimal p53 response element.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11384963     DOI: 10.1074/jbc.C100265200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes.

Authors:  Carol Mackintosh
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

2.  HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype.

Authors:  Penney M Gilbert; Janna K Mouw; Meredith A Unger; Johnathon N Lakins; Mawuse K Gbegnon; Virginia B Clemmer; Miriam Benezra; Jonathan D Licht; Nancy J Boudreau; Kelvin K C Tsai; Alana L Welm; Michael D Feldman; Barbara L Weber; Valerie M Weaver
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

Review 3.  The p53 circuit board.

Authors:  Kelly D Sullivan; Corrie L Gallant-Behm; Ryan E Henry; Jean-Luc Fraikin; Joaquín M Espinosa
Journal:  Biochim Biophys Acta       Date:  2012-02-07

4.  14-3-3sigma, the double-edged sword of human cancers.

Authors:  Zhaomin Li; Jing-Yuan Liu; Jian-Ting Zhang
Journal:  Am J Transl Res       Date:  2009-06-08       Impact factor: 4.060

5.  BRCA1 targets G2/M cell cycle proteins for ubiquitination and proteasomal degradation.

Authors:  S Shabbeer; D Omer; D Berneman; O Weitzman; A Alpaugh; A Pietraszkiewicz; S Metsuyanim; A Shainskaya; M Z Papa; R I Yarden
Journal:  Oncogene       Date:  2012-12-17       Impact factor: 9.867

6.  BRCA1 can modulate RNA polymerase II carboxy-terminal domain phosphorylation levels.

Authors:  Annie Moisan; Chantal Larochelle; Benoît Guillemette; Luc Gaudreau
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

7.  Interaction of 14-3-3σ with KCMF1 suppresses the proliferation and colony formation of human colon cancer stem cells.

Authors:  Jian Zou; Lin Mi; Xiao-Feng Yu; Jie Dong
Journal:  World J Gastroenterol       Date:  2013-06-28       Impact factor: 5.742

Review 8.  The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development.

Authors:  Deborah K Morrison
Journal:  Trends Cell Biol       Date:  2008-11-20       Impact factor: 20.808

9.  Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.

Authors:  Nam K Yoon; David B Seligson; David Chia; Yahya Elshimali; Giri Sulur; Ai Li; Steve Horvath; Erin Maresh; Vei Mah; Shikha Bose; Benjamin Bonavida; Lee Goodglick
Journal:  Cancer Biomark       Date:  2009       Impact factor: 4.388

10.  Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.

Authors:  Aaron G Lewis; James Flanagan; Anna Marsh; Gulietta M Pupo; Graham Mann; Amanda B Spurdle; Geoffrey J Lindeman; Jane E Visvader; Melissa A Brown; Georgia Chenevix-Trench
Journal:  Breast Cancer Res       Date:  2005-10-21       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.